McKesson (MCK) 10-K Summary — Year Ended Mar 31, 2024
McKesson is a diversified healthcare services company. In its most recent fiscal year, the company reported higher revenue and operating income compared to the prior year, with strong operating cash flow.
Key takeaway
Year ended Mar 31, 2024 · FY2026 10-K
McKesson is a diversified healthcare services company. In its most recent fiscal year, the company reported higher revenue and operating income compared to the prior year, with strong operating cash flow.
Financial snapshot
Selected annual figures reported with the filing, shown separately from the narrative summary.
Annual revenue
$309B
Revenue reported for the fiscal year.
Operating income
$3.9B
Income from operations reported for the year.
Net income
$3B
Net income reported for the year.
Operating cash flow
$4.3B
Cash generated by operating activities.
Annual revenue trend
Reported annual revenue and its change from the preceding fiscal year.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 31, 2022 | $264B | n/a |
| Mar 31, 2023 | $276.7B | +4.8% |
| Mar 31, 2024 | $309B | +11.7% |
Business overview
McKesson traces its roots to 1833 and is a diversified healthcare services leader. It partners with biopharma companies, providers, pharmacies, and others to make quality care more accessible and affordable. The company operates through segments including U.S. Pharmaceutical, Prescription Technology Solutions, Medical-Surgical Solutions, and International.
Financial performance
Revenue increased compared to the prior year. Operating income and net income also showed positive results. Operating cash flow was robust.
Material risks
The company faces risks from extensive government regulation and intense competition. Cybersecurity threats and legal proceedings are also identified as material risks. The filing notes that the company operates in a highly regulated industry.
Liquidity and capital
McKesson maintains a significant cash and cash equivalents balance. The company uses debt financing, as indicated by its debt to capital ratio, and has a working capital deficit.
What to watch
Readers should monitor the company's revenue growth trend in the next filing.